ShredMAX contains SLU-PP-332, a research-grade ERR receptor agonist that activates all three estrogen-related receptor subtypes – ERRα, ERRβ, and ERRγ – for laboratory investigation of mitochondrial pathways. Research teams use this compound to study cellular respiration mechanisms and ERR-dependent metabolic signaling in vitro. The molecule shows measurable receptor activation across ERR subtypes in controlled laboratory conditions. Produced under USA GMP standards with independent verification from three certified labs. COAs with every order. Strict research use only – not intended for human consumption. Although various research chemical vendors offer SLU-PP-332 in doses of 1mg per capsule, a re-evaluation of doses used in mouse studies (50 mg/kg twice daily) has found this practice to be unsatisfactory for examining the compound in laboratory settings. Therefore, we are introducing ShredMAX at 100mg per capsule to correct for this misinterpretation.
